MDxHealth S.A. (0O8G.L) LSE

3.02

-0.1804(-5.64%)

Updated at December 15, 2023 05:16PM

Currency In EUR

MDxHealth S.A.

Address

CAP Business Center

Herstal, 4040

Belgium

Phone

32 4 257 70 21

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

312

First IPO Date

August 05, 2008

Key Executives

NameTitlePayYear Born
Mr. Michael K. McGarrityChief Executive Officer & Executive Director764,4821963
Mr. Joseph Sollee J.D., LLMExecutive Vice President of Corporate Development & General Counsel01965
Mr. Ron Kalfus CPAChief Financial Officer01974
Ms. Miriam ReyesExecutive Vice President of Operations01973
Mr. John A. BellanoChief Commercial Officer01969

Description

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.